Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.
Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use …
Endometriosis, Anxiety, Allergic Rhinoconjunctivitis and Asthma: A population-based study.
To evaluate the association between endometriosis, anxiety, allergic rhinoconjunctivitis and asthma in hospitalized women, and to determine the role of age.
Adenomyosis Pathophysiology, Diagnostic Advances, and Therapeutic Options.
Adenomyosis is a heterogeneous, nonmalignant uterine disorder characterized by ectopic endometrium within the myometrium, leading to abnormal uterine bleeding, dysmenorrhea, chronic pelvic pain, and subfertility. Once considered a disease of …
Surgery for Pain Symptoms in Women with Isolated Superficial Peritoneal Endometriosis.
To evaluate change in overall pain after surgery in participants with suspected isolated superficial peritoneal endometriosis (iSPE), and to identify improvement predictors.